Korean J Intern Med.
2023 Nov;38(6):785-786. 10.3904/kjim.2023.437.
Identifying and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
- Jeon Y
1,2,3
- Affiliations
-
- 1Lymphoma and Cell-therapy Research Center, Yeouido St. Mary’s Hospital, School of Medicine, The Catholic University of Korea, Seoul, Korea
- 2Department of Hematology, Yeouido St. Mary’s Hospital, School of Medicine, The Catholic University of Korea, Seoul, Korea
- 3JL’s Lymphoma Origins & Clinical Applications Lab (JL-LOCAL), The Catholic University of Korea, Seoul, Korea
- KMID: 2547636
- DOI: http://doi.org/10.3904/kjim.2023.437
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
- Is there a relationship between the infusion-related reaction and effect of rituximab in the treatment of patients with diffuse large B-cell lymphoma?
- Treatment of Diffuse Large B Cell Lymphoma
- Primary Diffuse Large B Cell Lymphoma of the Bladder
- Radioimmunotherapy with 131I-Rituximab in a Patient with Diffuse Large B-Cell Lymphoma Relapsed After Treatment with 90Y-Ibritumomab Tiuxetan
